NO130048B - - Google Patents
Download PDFInfo
- Publication number
- NO130048B NO130048B NO04610/71*[A NO461071A NO130048B NO 130048 B NO130048 B NO 130048B NO 461071 A NO461071 A NO 461071A NO 130048 B NO130048 B NO 130048B
- Authority
- NO
- Norway
- Prior art keywords
- machine according
- concrete
- feeding belt
- wall
- container
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims 4
- 230000007423 decrease Effects 0.000 claims 2
- 238000005056 compaction Methods 0.000 claims 1
- 230000006835 compression Effects 0.000 claims 1
- 238000007906 compression Methods 0.000 claims 1
- 238000007493 shaping process Methods 0.000 claims 1
- 238000009751 slip forming Methods 0.000 claims 1
- SPJMAPNWDLIVRR-UHFFFAOYSA-M sodium;3-chloro-2-phenylphenolate Chemical compound [Na+].[O-]C1=CC=CC(Cl)=C1C1=CC=CC=C1 SPJMAPNWDLIVRR-UHFFFAOYSA-M 0.000 claims 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 24
- 150000001875 compounds Chemical class 0.000 description 14
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 235000019256 formaldehyde Nutrition 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000001882 diuretic effect Effects 0.000 description 6
- 229930040373 Paraformaldehyde Natural products 0.000 description 5
- -1 alkali metal salts Chemical class 0.000 description 5
- IHJCXVZDYSXXFT-UHFFFAOYSA-N chloraminophenamide Chemical compound NC1=CC(Cl)=C(S(N)(=O)=O)C=C1S(N)(=O)=O IHJCXVZDYSXXFT-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 229960002155 chlorothiazide Drugs 0.000 description 4
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 230000001452 natriuretic effect Effects 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 229920002866 paraformaldehyde Polymers 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M lithium hydroxide Inorganic materials [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- JVMPQYRPGCRZQH-UHFFFAOYSA-N 3-pentyl-4h-1$l^{6},2,4-benzothiadiazine 1,1-dioxide Chemical compound C1=CC=C2NC(CCCCC)=NS(=O)(=O)C2=C1 JVMPQYRPGCRZQH-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000029422 Hypernatremia Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N anhydrous diethylene glycol Natural products OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical class Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 208000009928 nephrosis Diseases 0.000 description 1
- 231100001027 nephrosis Toxicity 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B28—WORKING CEMENT, CLAY, OR STONE
- B28B—SHAPING CLAY OR OTHER CERAMIC COMPOSITIONS; SHAPING SLAG; SHAPING MIXTURES CONTAINING CEMENTITIOUS MATERIAL, e.g. PLASTER
- B28B1/00—Producing shaped prefabricated articles from the material
- B28B1/08—Producing shaped prefabricated articles from the material by vibrating or jolting
- B28B1/084—Producing shaped prefabricated articles from the material by vibrating or jolting the vibrating moulds or cores being moved horizontally for making strands of moulded articles
Landscapes
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Chemical & Material Sciences (AREA)
- Ceramic Engineering (AREA)
- Mechanical Engineering (AREA)
- Devices For Post-Treatments, Processing, Supply, Discharge, And Other Processes (AREA)
- On-Site Construction Work That Accompanies The Preparation And Application Of Concrete (AREA)
- Manufacturing Of Tubular Articles Or Embedded Moulded Articles (AREA)
- Press-Shaping Or Shaping Using Conveyers (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1695670 | 1970-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO130048B true NO130048B (en:Method) | 1974-07-01 |
Family
ID=20303048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO04610/71*[A NO130048B (en:Method) | 1970-12-15 | 1971-12-14 |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5417766B1 (en:Method) |
| AT (1) | AT318458B (en:Method) |
| BE (1) | BE775319A (en:Method) |
| CA (1) | CA946593A (en:Method) |
| CH (1) | CH537263A (en:Method) |
| CS (1) | CS159298B2 (en:Method) |
| DE (1) | DE2152124B2 (en:Method) |
| DK (1) | DK126976B (en:Method) |
| ES (2) | ES398005A1 (en:Method) |
| FI (1) | FI52676C (en:Method) |
| FR (1) | FR2118494A5 (en:Method) |
| GB (1) | GB1337298A (en:Method) |
| HU (1) | HU171636B (en:Method) |
| IL (1) | IL38322A (en:Method) |
| IT (1) | IT940056B (en:Method) |
| NL (1) | NL158424B (en:Method) |
| NO (1) | NO130048B (en:Method) |
| SU (1) | SU438162A3 (en:Method) |
| ZA (1) | ZA718140B (en:Method) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2128654A (en) * | 1982-10-12 | 1984-05-02 | Balfour Beatty Ltd | Wall panel |
| IT1195098B (it) * | 1986-07-11 | 1988-10-12 | Russo A & C Sas | Impianto per la produzione su pista di pannelli alveolari in cemento armato precompresso o parzialmente precompresso o con armatura lenta estesa alle superfici inferiore e superiore ed alle costole e prodotto derivato |
| FR2671119B1 (fr) * | 1990-12-28 | 1993-04-09 | Saret France | Elements de construction en beton, precontraint, du type predalles, installation et procede pour leur fabrication. |
| ES2155293B1 (es) * | 1997-02-04 | 2001-12-16 | Extremadura 2000 De Estructura | Procedimiento de fabricacion de placas pretensadas tipo pi por extrusion. |
-
1971
- 1971-10-18 CA CA125,319A patent/CA946593A/en not_active Expired
- 1971-10-19 AT AT902971A patent/AT318458B/de not_active IP Right Cessation
- 1971-10-19 GB GB4847071A patent/GB1337298A/en not_active Expired
- 1971-10-20 DE DE2152124A patent/DE2152124B2/de active Granted
- 1971-10-27 IT IT70522/71A patent/IT940056B/it active
- 1971-10-29 DK DK529171AA patent/DK126976B/da unknown
- 1971-10-30 CH CH1574271A patent/CH537263A/de not_active IP Right Cessation
- 1971-11-02 SU SU1710624A patent/SU438162A3/ru active
- 1971-11-03 FI FI713135A patent/FI52676C/fi active
- 1971-11-12 BE BE775319A patent/BE775319A/xx unknown
- 1971-11-14 NL NL7115634.A patent/NL158424B/xx unknown
- 1971-11-17 JP JP9157371A patent/JPS5417766B1/ja active Pending
- 1971-12-01 FR FR7143960A patent/FR2118494A5/fr not_active Expired
- 1971-12-06 ZA ZA718140A patent/ZA718140B/xx unknown
- 1971-12-08 IL IL38322A patent/IL38322A/en unknown
- 1971-12-10 HU HU71NI00000143A patent/HU171636B/hu unknown
- 1971-12-14 CS CS869071A patent/CS159298B2/cs unknown
- 1971-12-14 NO NO04610/71*[A patent/NO130048B/no unknown
- 1971-12-15 ES ES398005A patent/ES398005A1/es not_active Expired
- 1971-12-15 ES ES398004A patent/ES398004A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2152124A1 (de) | 1972-07-20 |
| ES398005A1 (es) | 1974-07-01 |
| AU3490371A (en) | 1973-05-03 |
| DE2152124C3 (en:Method) | 1974-09-19 |
| CH537263A (de) | 1973-05-31 |
| IL38322A0 (en) | 1972-02-29 |
| ES398004A1 (es) | 1974-07-01 |
| BE775319A (fr) | 1972-03-01 |
| IT940056B (it) | 1973-02-10 |
| FR2118494A5 (en:Method) | 1972-07-28 |
| AT318458B (de) | 1974-10-25 |
| DK126976B (da) | 1973-09-10 |
| IL38322A (en) | 1974-12-31 |
| DE2152124B2 (de) | 1974-02-14 |
| CA946593A (en) | 1974-05-07 |
| NL158424B (nl) | 1978-11-15 |
| CS159298B2 (en:Method) | 1974-12-27 |
| FI52676B (en:Method) | 1977-08-01 |
| GB1337298A (en) | 1973-11-14 |
| NL7115634A (en:Method) | 1972-06-19 |
| SU438162A3 (ru) | 1974-07-30 |
| FI52676C (fi) | 1977-12-01 |
| ZA718140B (en) | 1972-08-30 |
| JPS5417766B1 (en:Method) | 1979-07-03 |
| HU171636B (hu) | 1978-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK145676B (da) | Analogifremgangsmaade til fremstilling af oxoalkyldialkylxanthiner | |
| GB1592272A (en) | Fused thiazolidine derivatives and process for their manufacture | |
| NO139918B (no) | Nye ioniske jodbenzenderivater for anvendelse i roentgenkontrastmidler | |
| CN114437034A (zh) | 一种酞嗪类化合物的可药用盐、晶型及其制备方法 | |
| EP2464638A1 (en) | Lenalidomide salts | |
| EP1194415B1 (en) | Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for their preparation | |
| NO130048B (en:Method) | ||
| JPH0150698B2 (en:Method) | ||
| SU488408A3 (ru) | Способ получени замещенных 3-(2-4фенил-1-пиперазинил-этил)-индолинов или их солей, или их четвертичных аммониевых солей | |
| NO138408B (no) | Forbindelse for anvendelse som utgangsmateriale for fremstilling av 1-(4-metzyl-6-metoksy-2-pyrimidinyl)-3-metyl-5-metoksypyrazol, og fremgangsmaate for fremstilling av forbindelsen | |
| PT100097A (pt) | Novos agentes terapeuticos constituidos por derivados de quinolina e processo para a sua preparacao | |
| NO137093B (no) | Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner | |
| NO150553B (no) | Oppblaasbar baat | |
| NO136574B (en:Method) | ||
| US2597445A (en) | Nu-alkylamino-methyl-phenyl-propane and method of preparing same | |
| NO125530B (en:Method) | ||
| Wibaut et al. | On the reactivity of the bromine atoms in brominated pyridines. the formation of 2, 6‐diamino‐4‐bromopyridine by the action of ammonia on 2, 4, 6‐tribromopyridine | |
| US2654753A (en) | 2-sulfanilamido-5-aminopyrimidine and salts thereof | |
| NO164934B (no) | Fremgangsmaate for maaling av trykk ved perforering av en foring i et borehull. | |
| NO137900B (no) | Analogifremgangsm}te til fremstilling av terapeutisk aktive, basisk substituerte teofyllin-derivater | |
| US2741615A (en) | N-substituted dihydrodesoxynorcodeine compounds | |
| CN109761911A (zh) | 一种用作Elagolix中间体的多取代嘧啶衍生物的制备方法 | |
| PL49637B1 (en:Method) | ||
| HU196392B (en) | Process for production of benzodioxephane-derivatives and medical preparatives containing them as active substance | |
| Lorette | Cleavage of Tetrahydrofuran by 2, 3-Dichloro-p-dioxane and 2, 3-Dichlorotetrahydrofuran Using Zinc Chloride as a Catalyst |